I was really impressed by the size and quality of the Drug Discovery 2014 organised by ELRIG in Manchester. More than 1,500 scientists participated in this meeting and nearly 100 exhibitors were present. Phentoypic screening and high content screening were prominent in this conference and we could hear researchers from Roche, Astrazeneca, Merck Serono or Cancer research UK / UK-NPSC (National Screening Phentypic center) to explain us how they have implemented phenotypic screening and HCA / HCS in their lab and process of drug discovery.
Here, you can hear an interesting interview from Dr. Peter Simpson, Co-Organizer of Elrig Drug Discovery 2014, directed by SelectScience :
Biomimesys
HCS Pharma at 8th Bioproduction congress in Lyon on october 4-6 2023
In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy Read more…
0 Comments